Surgery targets hidden nerve tethering in trigeminal neuralgia
NCT ID NCT07811973
First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time
Summary
Researchers at Assiut University are studying whether scar-like arachnoid tissue can tether the trigeminal nerve and cause facial pain in people whose MRI scans show no blood vessel pressing on the nerve. Adults with trigeminal neuralgia that has not responded to medication can join. During surgery, doctors look for and release any arachnoid adhesions using an endoscope, then track pain relief with standard scales.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Endoscopic-assisted arachnoid nerve detethering, a surgical procedure that releases scar-like tissue around the trigeminal nerve
- What this could lead to
- If it works, this could offer a surgical option for people with trigeminal neuralgia whose scans show no obvious cause and whose medications have failed.
- What could go wrong
- This is a small, single-center study with no control group, so any pain relief could reflect the placebo effect of surgery. Surgery near the trigeminal nerve carries risks of facial numbness, infection, and bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 23 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age more 18 * Failed medical treatment Exclusion Criteria: * Vascular compression * Tumors
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Trigeminal neuralgia are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an IV Anti-Seizure drug calm the lightning bolts of trigeminal neuralgia?
- Can freezing a nerve silence the 'Suicide Disease'?
- Pain relief showdown: one drug vs. two for facial nerve pain
- New combo therapy aims to calm face pain attacks
- Laser showdown: which light therapy zaps facial pain best?
- Massive study aims to predict brain surgery success